Last reviewed · How we verify
The drug "Rutan 0.1".
Rutan 0.1 is a phytopharmaceutical preparation that provides antiviral and immunomodulatory effects through its active bioflavonoid components.
Rutan 0.1 is a phytopharmaceutical preparation that provides antiviral and immunomodulatory effects through its active bioflavonoid components. Used for Viral infections (specific indications not fully characterized in available literature).
At a glance
| Generic name | The drug "Rutan 0.1". |
|---|---|
| Also known as | Rutan |
| Sponsor | Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan |
| Drug class | Phytopharmaceutical/Bioflavonoid preparation |
| Modality | Small molecule |
| Therapeutic area | Virology/Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Rutan contains rutin and related flavonoids derived from plant sources, which exhibit antiviral properties and may enhance immune function. The preparation is used in viral infections, particularly in regions where it has been developed and marketed. The exact molecular mechanisms remain incompletely characterized in peer-reviewed literature.
Approved indications
- Viral infections (specific indications not fully characterized in available literature)
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: